Cefosactu M 1000mg/500mg Injection
Marketer
Sacem Formulations
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Cefosactu M 1000mg/500mg Injection
Cefosactu M 1000mg/500mg injectable solution is a dual-action antibiotic, indicated for treating diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration must be strictly under medical guidance. Complete the prescribed regimen, even with symptom improvement; premature cessation compromises efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your physician. Seek prompt medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor about all concurrent medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing drowsiness or dizziness. Sufficient rest, a balanced diet, and adequate hydration are vital for optimal recovery. Your doctor may order laboratory tests to monitor the medication's effects.
Uses of Cefosactu M 1000mg/500mg Injection
Managing bacterial infections
Major Benefits of Cefosactu M 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefosactu M 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Cefosactu M 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Cefosactu M 1000mg/500mg Injection works:
Cefosactu M Injection (1000mg/500mg) combines the antibiotic Cefoperazone with the beta-lactamase inhibitor Sulbactam. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby augmenting Cefoperazone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Cefosactu M 1000mg/500mg Injection and alcohol may result in adverse effects including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Cefosactu M (1000mg/500mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Cefosactu M 1000mg/500mg Injection during lactation is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Cefosactu M 1000mg/500mg Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefosactu M 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefosactu M 1000mg/500mg Injection to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Cefosactu M 1000mg/500mg Injection :
Omit a Cefosactu M 1000mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Cefosactu M 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
3,018 People bought this recently